Status:
UNKNOWN
Role of Doppler Endoscopic Probe in the Diagnosis of Subepithelial Gastrointestinal Lesions.
Lead Sponsor:
Francisco Baldaque-Silva
Conditions:
Subepithelial Tumors of the Upper Gastrointestinal Tract
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RESEARCH PLAN I-TITLE Role of Doppler endoscopic probe in the diagnosis of subepithelial gastrointestinal lesions. II-BACKGROUND Subepithelial lesions (SEL) are commonly encountered during routine en...
Detailed Description
RESEARCH PLAN I-TITLE Role of doppler endoscopic probe in the diagnosis of subepithelial gastrointestinal lesions. II-BACKGROUND Subepithelial lesions (SELs) are commonly encountered on routine end...
Eligibility Criteria
Inclusion
- Presence of subepithelial lesion on the GI tract.
Exclusion
- Anticoagulation therapy that cannot be discontinued
- Liver cirrhosis with coagulopathy or varices
- Malignancy
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05983406
Start Date
August 1 2023
End Date
December 31 2023
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital & Karolinska Institute
Stockholm, Sweden, 11346